| Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children (NCT00429546) | University of California, Los Angeles | 2007-09-01 |
| Neighborhood Alcohol & HIV Prevention in South African Townships (Philani) (NCT00996528) | University of California, Los Angeles | 2007-09-01 |
| Men of African American Legacy Empowering Self (NCT01492530) | Charles Drew University of Medicine and Science | 2007-08-01 |
| HIV Prevention Among Vulnerable Male Youth (NCT01771237) | Ann & Robert H Lurie Children's Hospital of Chicago | 2007-07-01 |
| Pregnant Women's CoOp (NCT00722670) | RTI International | 2007-06-01 |
| Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya (NCT00830622) | University of Manitoba | 2007-05-01 |
| Case Management Alternatives for African American Women at High Risk for HIV (NCT00780260) | Nova Southeastern University | 2007-05-01 |
| Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics (NCT00668395) | Indiana University | 2007-05-01 |
| EuroSIDA As An External Comparator To MOTIVATE Trials (NCT01329783) | ViiV Healthcare | 2007-04-01 |
| Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments (NCT01445314) | National Cancer Institute (NCI) | 2007-03-23 |
| Accuracy of Hemoglobin A1C to Predict Glycemia in HIV (NCT00433628) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-02-07 |
| Intervention for Newly Diagnosed Youth With HIV (NCT00510237) | University of North Carolina, Chapel Hill | 2007-02-01 |
| The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet (NCT00766818) | University of North Carolina, Chapel Hill | 2007-01-01 |
| HIV Viral Load Monitoring in Resource-Poor Settings (NCT00929604) | University of Alabama at Birmingham | 2006-12-01 |
| Development of a Methamphetamine Early Intervention (NCT01174654) | University of Washington | 2006-12-01 |
| HIV Testing & Womens Attitudes on HIV Vaccine Trials (NCT00771537) | Indiana University | 2006-11-01 |
| GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. (NCT00381303) | Tibotec, Inc | 2006-11-01 |
| Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy (NCT00367458) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-18 |
| Addressing Young Men's Substance Use and HIV Risk (NCT00325702) | Public Health Management Corporation | 2006-10-01 |
| Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users (NCT01741350) | University of Connecticut | 2006-09-01 |
| Genetics and HIV-1 Protease Inhibitors (NCT01388543) | University of Colorado, Denver | 2006-09-01 |
| Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients (NCT00299091) | Germans Trias i Pujol Hospital | 2006-09-01 |
| Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya (NCT00838292) | Academy for Educational Development | 2006-08-01 |
| Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects (NCT00960622) | St. Luke's-Roosevelt Hospital Center | 2006-08-01 |
| Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients (NCT00358696) | University of British Columbia | 2006-07-01 |
| Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy (NCT00959361) | Hospital de Clinicas de Porto Alegre | 2006-06-01 |
| Risk Reduction Intervention for Vulnerable Young Adult Males (NCT01118416) | Hunter College of City University of New York | 2006-06-01 |
| Sildenafil to Treat HIV-Associated Pulmonary Hypertension (NCT00327080) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-05-12 |
| Alveolar Macrophage Proteomics in HIV-associated Emphysema (NCT00823927) | Philip Diaz | 2006-04-21 |
| Nutrition, Diabetes and Pulmonary TB/HIV (NCT00311298) | University of Copenhagen | 2006-04-01 |
| A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination (NCT00335270) | Duke University | 2006-03-01 |
| Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda (NCT00342160) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-15 |
| Intervention Development for Newly Diagnosed Youth With HIV (NCT00255892) | University of North Carolina, Chapel Hill | 2006-02-01 |
| Extending HIV Care Beyond the Rural Health Center (NCT00371540) | Indiana University | 2006-02-01 |
| Shaping the Health of Adolescents in Zimbabwe (NCT02034214) | University of California, San Francisco | 2006-02-01 |
| Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART. (NCT00298350) | Gilead Sciences | 2006-02-01 |
| Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV (NCT00295477) | University of Pennsylvania | 2006-01-01 |
| Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients (NCT00270465) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-21 |
| Integrating Buprenorphine Into the SFGH AIDS Program (NCT00263458) | University of California, San Francisco | 2005-12-01 |
| Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study (NCT00344487) | University of Maryland, Baltimore | 2005-12-01 |
| TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. (NCT00255099) | Tibotec Pharmaceuticals, Ireland | 2005-12-01 |
| The Efficacy of the HIV/AIDS Symptom Management Manual (NCT00241202) | University of California, San Francisco | 2005-10-01 |
| High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease (NCT00247143) | Lampiris, Harry W., M.D. | 2005-10-01 |
| A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients (NCT00246298) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-10-01 |
| TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications. (NCT00258557) | Tibotec Pharmaceuticals, Ireland | 2005-09-01 |
| Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) (NCT00798538) | Yale University | 2005-08-01 |
| Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100) (NCT00686829) | Merck Sharp & Dohme LLC | 2005-06-30 |
| Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV (NCT03324633) | ANRS, Emerging Infectious Diseases | 2005-06-01 |
| Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV (NCT00271856) | University of California, San Francisco | 2005-05-01 |
| A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial (NCT00250549) | North Bronx Healthcare Network | 2005-05-01 |
| Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics (NCT01386970) | University of Colorado, Denver | 2005-05-01 |
| HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection (NCT00476723) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-04-01 |
| Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED) (NCT00850616) | Merck Sharp & Dohme LLC | 2005-04-01 |
| Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP (NCT00204308) | University of North Carolina, Chapel Hill | 2005-03-01 |
| Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents (NCT00137644) | Centers for Disease Control and Prevention | 2005-03-01 |
| Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment (NCT00105417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Assessing the Impact of an Intervention to Prevent Intimate Partner Violence and HIV in Uganda (NCT02050763) | Johns Hopkins Bloomberg School of Public Health | 2005-02-01 |
| Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research (NCT00341042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-04 |
| To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir (NCT00335192) | Germans Trias i Pujol Hospital | 2005-01-01 |
| A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials (NCT02187107) | Tibotec Pharmaceuticals, Ireland | 2005-01-01 |
| NOW Thai HAART Study (NCT00367731) | Department of Medical Services Ministry of Public Health of Thailand | 2005-01-01 |
| A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand (NCT00362596) | Centers for Disease Control and Prevention | 2005-01-01 |
| Exercise and Pioglitazone for HIV-Metabolic Syndromes (NCT00639457) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-01-01 |
| Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity (NCT00092222) | National Cancer Institute (NCI) | 2004-10-28 |
| The Treatment Advocacy Program (NCT00164333) | Centers for Disease Control and Prevention | 2004-09-01 |
| Computer-Assisted HIV Prevention for Young Drug Users (NCT00182585) | National Development and Research Institutes, Inc. | 2004-08-01 |
| Motivating HIV+ Women: Risk Reduction and ART Adherence (NCT00253045) | Emory University | 2004-08-01 |
| Housing and Health Study (NCT00153504) | Centers for Disease Control and Prevention | 2004-07-01 |
| Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY (NCT00235222) | Groupe Hospitalier Pitie-Salpetriere | 2004-06-01 |
| Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST) (NCT00851630) | Duke University | 2004-06-01 |
| Project TEAM: Teaching HIV Prevention in the HIV Clinic (NCT00164320) | Centers for Disease Control and Prevention | 2004-05-01 |
| A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV) (NCT01445223) | Göteborg University | 2004-04-01 |
| A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine (NCT00344461) | University of Maryland, Baltimore | 2004-03-01 |
| Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. (NCT00139178) | Danish HIV Research Group | 2004-03-01 |
| Arginine as an Adjuvant Treatment Against Tuberculosis (NCT00857402) | Linkoeping University | 2004-02-01 |
| Epidemiological Study of HIV in the South African National Defense Force (NCT00341887) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-14 |
| Antiretroviral Therapy for Advanced HIV Disease in South Africa (NCT00342355) | National Institutes of Health Clinical Center (CC) | 2004-01-01 |
| Upper Gastrointestinal Endoscopy in HIV-infected Individuals (NCT07425067) | Centre Hospitalier Universitaire Saint Pierre | 2004-01-01 |
| TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV. (NCT00650832) | Tibotec Pharmaceuticals, Ireland | 2003-10-01 |
| Chronic Hepatitis Intervention Project for Drug Users (NCT00596843) | National Institute on Drug Abuse (NIDA) | 2003-09-01 |
| Painful HIV Neuropathy and Alpha-Lipoic Acid (NCT00079807) | National Center for Complementary and Integrative Health (NCCIH) | 2003-09-01 |
| Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients (NCT00286377) | Savient Pharmaceuticals | 2003-09-01 |
| HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy (NCT00393302) | Unity Health Toronto | 2003-09-01 |
| Study of Lifestyle Modification in HIV Lipodystrophy (NCT00111358) | Massachusetts General Hospital | 2003-06-01 |
| Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI) (NCT00264823) | National Institute of Nursing Research (NINR) | 2003-06-01 |
| A Network & Dyad HIV Prevention Intervention for IDU's - 1 (NCT00218335) | Johns Hopkins Bloomberg School of Public Health | 2003-06-01 |
| Project RESPECT: The Efficacy of HIV/STD Prevention Counseling (NCT00362791) | Centers for Disease Control and Prevention | 2003-04-01 |
| Effectiveness of HIV Risk Reduction Program Among African American Men (NCT00314028) | Richard Crosby | 2003-04-01 |
| Reducing Risk and Trauma-Related Stress in Persons Living With HIV (NCT00186030) | Stanford University | 2003-04-01 |
| Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV (NCT00329251) | Hospital Clinic of Barcelona | 2003-04-01 |
| Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART (NCT00516581) | UPECLIN HC FM Botucatu Unesp | 2003-02-01 |
| HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT (NCT00380770) | University of KwaZulu | 2003-01-01 |
| Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART. (NCT00270556) | Gilead Sciences | 2003-01-01 |
| Penetration and Compartimentation of HIV (NCT02513758) | Centre Hospitalier Universitaire de Saint Etienne | 2002-11-01 |
| Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access (NCT01003990) | Bristol-Myers Squibb | 2002-10-01 |
| ITV Extension Study (NCT00332930) | Kirby Institute | 2002-09-01 |
| In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults (NCT00144352) | Centers for Disease Control and Prevention | 2002-09-01 |
| Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda (NCT00339456) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-21 |
| NISDI Pediatric Latin American Countries Epidemiologic Study (PLACES): A Prospective Observational Study of HIV-Infected Children at Clinical Sites in Latin American Countries (NCT00339612) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-07-30 |
| HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS) (NCT00339430) | National Cancer Institute (NCI) | 2002-07-15 |